Experienced in Prostate Cancer

Marketa Skala

Hobart, TAS, AU 
Experienced in Prostate Cancer
Hobart, TAS, AU 
OverviewLocationsClinical Research

Overview

Marketa Skala practices in Hobart, Australia. Ms. Skala is rated as an Experienced expert by MediFind in the treatment of Prostate Cancer. Her top areas of expertise are Pulmonary Sequestration, Familial Prostate Cancer, and Prostate Cancer.

Her clinical research consists of co-authoring 21 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 15 articles and participated in 1 clinical trial in the study of Prostate Cancer.

Gender
Female

Locations

Hobart, TAS, Australia
Other Locations
Launceston, TAS, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Randomised Phase 3 Trial of Enzalutamide in Androgen Deprivation Therapy With Radiation Therapy for High Risk, Clinically Localised, Prostate Cancer: ENZARAD
Randomised Phase 3 Trial of Enzalutamide in Androgen Deprivation Therapy With Radiation Therapy for High Risk, Clinically Localised, Prostate Cancer: ENZARAD
Enrollment Status: Active_not_recruiting
Publish Date: May 30, 2025
Intervention Type: Drug, Radiation
Study Drugs: Enzalutamide, Conventional NSAA, LHRHA
Study Phase: Phase 3
A Randomised Comparison of Anastrozole Commenced Before and Continued During Adjuvant Radiotherapy for Breast Cancer Versus Anastrozole and Subsequent Anti-oestrogen Therapy Delayed Until After Radiotherapy.
A Randomised Comparison of Anastrozole Commenced Before and Continued During Adjuvant Radiotherapy for Breast Cancer Versus Anastrozole and Subsequent Anti-oestrogen Therapy Delayed Until After Radiotherapy.
Enrollment Status: Unknown
Publish Date: November 18, 2022
Intervention Type: Drug, Radiation
Study Drugs: Pre-Radiotherapy Commencement of Anastrozole, Post Radiotherapy Commencement of Anastrozole
Study Phase: Phase 3
IDH Mutated 1p/19q Intact Lower Grade Glioma Following Resection: Wait Or Treat? IWOT - a Phase III Study
IDH Mutated 1p/19q Intact Lower Grade Glioma Following Resection: Wait Or Treat? IWOT - a Phase III Study
Enrollment Status: Terminated
Publish Date: February 01, 2022
Intervention Type: Radiation, Drug, Procedure
Study Drug: Temozolomide
Study Phase: Phase 3
A Randomised Phase II Trial of Adaptive Image Guided Standard or Dose Escalated Tumour Boost Radiotherapy in the Treatment of Transitional Cell Carcinoma of the Bladder
A Randomised Phase II Trial of Adaptive Image Guided Standard or Dose Escalated Tumour Boost Radiotherapy in the Treatment of Transitional Cell Carcinoma of the Bladder
Enrollment Status: Active_not_recruiting
Publish Date: June 09, 2020
Intervention Type: Radiation
Study Phase: Phase 2
View 3 Less Clinical Trials

21 Total Publications

Extralobar pulmonary sequestration as an intraabdominal tumour.
Extralobar pulmonary sequestration as an intraabdominal tumour.
Journal: Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti
Published: July 14, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Skala's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile